Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.58 SEK | -0.76% | +10.31% | +140.66% |
Apr. 23 | Moberg Pharma AB Announces Launch Update for Mob-015 | CI |
Apr. 08 | Moberg Pharma AB Submits Application to Include an Additional Terbinafine Supplier | CI |
Sales 2022 | 207K 19.14K | Sales 2023 | - | Capitalization | 425M 39.3M |
---|---|---|---|---|---|
Net income 2022 | -15M -1.39M | Net income 2023 | -21M -1.94M | EV / Sales 2022 | 524 x |
Net cash position 2022 | 119M 11.04M | Net cash position 2023 | 55.82M 5.16M | EV / Sales 2023 | - |
P/E ratio 2022 |
-11
x | P/E ratio 2023 |
-11.4
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.9% |
1 day | -0.76% | ||
1 week | +10.31% | ||
Current month | +7.15% | ||
1 month | +6.52% | ||
3 months | +87.59% | ||
6 months | +330.35% | ||
Current year | +140.66% |
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 36.58 | -0.76% | 226,592 |
24-05-02 | 36.86 | +7.97% | 727,270 |
24-04-30 | 34.14 | +0.41% | 141,871 |
24-04-29 | 34 | +2.53% | 226,797 |
24-04-26 | 33.16 | -2.87% | 215,765 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+140.66% | 94.69M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- MOB Stock